Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TrueBlue, Inc.TBI · Entity 5919 | Director | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TrueBlue, Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,381 |
Reported balance
After 2026-02-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-20 · Grant · Acquired 27,566 · Balance 85,381 F1: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2: This total includes 71,664 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors.
F2: This total includes 71,664 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 24, 2026 15:47 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantCommon Stock | 27,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001473869-26-000002 · wk-form4_1771948064.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,381 F1 · shares: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2 · balance_after: This total includes 71,664 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 15:44 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantCommon Stock | 17,158 | $0.00 | $0.00 |
DisclosureSEC source: 0000768899-25-000057 · wk-form4_1740498270.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,815 F1 · shares: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full one (1) year from the grant date. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2 · balance_after: This total includes 44,098 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 17:53 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantCommon Stock | 9,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000768899-24-000047 · wk-form4_1709056426.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,657 F1 · shares: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full on September 30, 2024, which is the first day of the Issuer's fourth quarter in the current fiscal year. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2 · balance_after: This total includes 26,940 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 00:29 UTC | TrueBlue, Inc. TBI · Entity 5919 | PurchaseCommon Stock | 10,000 | $11.07 | $110,700.00 |
DisclosureSEC source: 0000768899-23-000137 · wk-form4_1698884942.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,136 F1 · price: This transaction was executed in multiple trades at prices ranging from $10.99 to $11.11. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, the detailed information regarding the number of shares purchased at each separate price. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:35 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantCommon Stock | 6,741 | $0.00 | $0.00 |
DisclosureSEC source: 0000768899-23-000022 · wf-form4_167580930149530.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,136 F1 · shares: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full on September 25, 2023, which is the first day of the Issuer's fourth quarter in the current fiscal year. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2 · balance_after: This total includes 17,419 shares deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:36 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantCommon Stock | 4,956 | $0.00 | $0.00 |
DisclosureSEC source: 0000768899-22-000027 · wf-form4_164434895042441.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,395 F1 · shares: Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full on September 26, 2022, which is the first day of the Issuer's fourth quarter in the current fiscal year. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2 · balance_after: This total includes 10,678 shares or restricted stock units, as applicable, deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors, of which 5,722 were previously reported in Table II. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 18:36 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantRestricted Stock Units · Derivative | 5,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000768899-21-000024 · wf-form4_161280938274739.xml · derivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,722 Underlying: Common Stock · 5,722 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TrueBlue, Inc. common stock in the future. F2 · derivative.exercise_date: The restricted stock units will vest in full on September 27, 2021, which is the first day of the Issuer's fourth quarter in the current fiscal year. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. F2 · derivative.expiration_date: The restricted stock units will vest in full on September 27, 2021, which is the first day of the Issuer's fourth quarter in the current fiscal year. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 19:21 UTC | TrueBlue, Inc. TBI · Entity 5919 | GrantCommon Stock | 3,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000768899-20-000116 · wf-form4_159656885537149.xml · nonDerivative · entry 1 Kreidler Robert C. · CIK 0001473869 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,717 F1 · shares: The shares acquired represent a grant of restricted stock that will 100% vest on the first day of the Issuer's fourth quarter in the current fiscal year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.